Eton Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $25.9M | $14.9M | $21.4M | $16.3M | $14.4M | $21.3M | $12.1M | $26.7M |
| Accounts Receivable | $11.8M | $5.4M | $3.4M | $1.9M | $5.5M | $48.0K | $473.0K | — |
| Inventory | $15.4M | $15.2M | $911.0K | $557.0K | $550.0K | $1.2M | $380.0K | — |
| Total Current Assets | $60.6M | $41.0M | $26.8M | $20.0M | $23.6M | $24.7M | $15.0M | $27.5M |
| Property, Plant & Equipment | $326.0K | $34.0K | $58.0K | $72.0K | $115.0K | $811.0K | $1.1M | $773.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $30.9M | $34.9M | $4.7M | $4.8M | $3.6M | $575.0K | $725.0K | — |
| Total Assets | $92.1M | $76.1M | $31.7M | $25.0M | $27.5M | $26.3M | $17.1M | $28.3M |
| Liabilities | ||||||||
| Accounts Payable | $11.0M | $4.2M | $1.8M | $1.8M | $1.8M | $2.3M | $575.0K | $1.4M |
| Total Current Liabilities | $38.5M | $19.9M | $16.2M | $6.5M | $4.6M | $3.8M | $2.0M | $2.0M |
| Long-Term Debt | $21.8M | $29.8M | $0 | $5.4M | $5.3M | $6.5M | $4.5M | — |
| Total Liabilities | $66.0M | $51.7M | $16.3M | $12.0M | $9.8M | $10.7M | $6.5M | $2.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-112.5M | $-107.9M | $-104.1M | $-103.1M | $-94.1M | $-92.2M | $-64.2M | $-45.9M |
| Total Stockholders' Equity | $26.2M | $24.4M | $15.5M | $13.1M | $17.6M | $17.6M | $10.6M | $26.3M |